Allied Market Research

Cough Remedies Market Forecast 2023


Portland, OR -- (SBWIRE) -- 09/11/2017 -- Cough is a reflex action that clears the throat from fluids, irritants, foreign particles, and microbes. It is majorly caused by virus or bacteria, smoking, asthma, and other factors. Cough drops and suppressants are majorly given to the patient to cure cough. Sometimes, the patient is also advised to drink plenty of water, as a measure for cough remedy.

Increase in geriatric population, who are more prone to cough and cold, rise in vehicle pollution, high demand of over-the-counter products, development in R&D activities, and growth in awareness about advanced medicines drive the market. However, stringent government regulations and side effects associated with it restrain the market growth. More number of cough cases, development of advanced products, such as use of effective treatments (inhaled corticosteroids for asthma-related cough) make way for lucrative growth opportunities for the market.

Access the full summary at :

Get PDF Brochure of this report:

The key players operating in this market include Johnson & Johnson, Reckitt Benckiser Group plc, Bayer AG, GlaxoSmithKline plc., AstraZeneca, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Prestige Brands, Inc., and Procter & Gamble.

Cough Remedies Market Key Segments:

By Type

By Dosage Form
-Oral Syrups
-Nasal Drops

By Distribution Channel
-Hospital Pharmacies
-Retail Pharmacies
-Drug Stores
-e-Commerce/Online Pharmacies

Early buyers will receive 20% customization on this report